The Aging Brain Proteomics Team is dedicated to understanding the molecular mechanisms underlying aging and neurodegenerative diseases. Our team employs advanced proteomics technologies to analyze protein expressions, modifications, and interactions in aging brain tissues. By identifying key proteins and pathways involved in brain aging, we aim to uncover potential biomarkers and therapeutic targets to combat age-related cognitive decline and neurodegenerative disorders. Our research integrates multidisciplinary approaches, combining proteomics with genomics, bioinformatics, and clinical studies, to provide comprehensive insights into the aging brain.